Essais liés4clinical trials
VilleLublinlocalisation
PaysPolandlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03832998

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
Erenumab Dose 1 Migraine Phase 3 NCT03832998 OASIS(CM) — Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine COMPLETED
Erenumab Dose 1 Migraine Phase 3 NCT03836040 OASIS(EM) — Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine ACTIVE_NOT_RECRUITING
Lu AG09222 Migraine Phase 2 NCT06323928 PROCEED — A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments COMPLETED
Rimegepant Migraine Phase 3 NCT06616194 A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine ACTIVE_NOT_RECRUITING